13F Holdings
中文EN

FMS Fresenius Medical Care AG IFRS

Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 1333141 · Reporting currency EUR

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.5%
TTM net income YoY81.9%
TTM EPS YoY83.6%
Revenue 3-yr CAGR0.4%
Net income 3-yr CAGR13.3%

Margins

Gross margin25.6%
Operating margin9.3%
Net margin5.0%
FCF margin—
EBITDA margin16.8%

Returns

ROE7.0%
ROA3.0%
ROIC (approx.)7.3%
Asset turnover0.61x

Leverage & solvency

Liabilities / assets53.9%
Debt / equity0.55x
Current ratio1.26x
Interest coverage4.87x

Cash quality & payout

Operating cash flow / net income2.74x
Accruals ratio-5.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: EUR FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue19.63B19.34B19.45B19.40B17.62B
Cost of revenue14.60B14.58B14.53B14.50B12.85B
Gross profit5.03B4.76B4.93B5.31B5.08B
R&D expense157.97M183.49M231.97M228.62M220.78M
SG&A expense3.03B3.14B3.20B3.17B2.77B
Operating income1.83B1.39B1.37B1.51B1.85B
Interest expense375.22M393.32M424.64M360.14M353.60M
Pretax income1.51B1.06B1.03B1.22B1.57B
Income tax320.97M316.06M300.56M324.95M352.83M
Net income978.37M537.91M499.00M673.40M969.31M
EBITDA3.29B2.93B2.98B3.23B3.44B
EPS (basic)3.361.831.702.303.31
EPS (diluted)3.361.831.702.303.31
Banking
Net interest income-314.80M-335.47M-336.42M-292.48M-280.43M
Balance sheet
Cash & equivalents1.60B1.18B1.40B1.27B1.48B
Inventory2.14B2.07B2.18B2.30B2.04B
Current assets7.90B7.92B8.70B8.20B7.97B
PP&E, netmay include right-of-use assets (IFRS)3.49B3.65B3.78B4.15B4.24B
Goodwill13.57B15.17B14.65B15.79B14.36B
Intangibles1.25B1.37B1.36B1.52B1.46B
Total assets31.00B33.57B33.93B35.75B34.37B
Current liabilities6.25B5.66B6.11B6.47B7.26B
Short-term debt1.60B575.28M456.90M648.77M1.26B
Long-term debt5.69B6.26B6.96B7.17B6.65B
Total debt7.29B6.84B7.42B7.82B7.90B
Total liabilities16.72B17.80B19.10B20.30B20.39B
Shareholders' equity13.31B14.58B13.62B13.99B12.70B
Net debt5.69B5.66B6.01B6.55B6.42B
Shares outstanding279.29M293.41M293.41M293.41M293.00M
Cash flow statement
Operating cash flow2.68B2.39B2.63B2.17B2.49B
Investing cash flow-722.53M-84.94M-544.23M-734.73M-1.20B
Financing cash flow-1.40B-2.57B-1.86B-1.62B-1.02B
Depreciation & amortization1.46B1.54B1.61B1.72B1.59B
Dividends paid422.51M349.16M328.62M395.56M392.45M
Share buybacks585.28M————

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· Amounts are in the company's reporting currency, EUR, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.